Charles Schwab’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Charles Schwab’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-78,073	Closed	-$383K	–	3709
2024 Q1	$383K	Sell	78,073 -6,144	-7%	-$29.2K	﹤0.01%	3119
2023 Q4	$307K	Hold	84,217	–	–	﹤0.01%	3215
2023 Q3	$187K	Buy	84,217 +10,831	+15%	+$30.2K	﹤0.01%	3297
2023 Q2	$250K	Buy	73,386 +11,579	+19%	+$41.8K	﹤0.01%	3270
2023 Q1	$247K	Hold	61,807	–	–	﹤0.01%	3126
2022 Q4	$336K	Buy	61,807 +77	+0.1%	+$453	﹤0.01%	3088
2022 Q3	$311K	Buy	61,730 +14,616	+31%	+$72K	﹤0.01%	3107
2022 Q2	$180K	Buy	+47,114	New	+$301K	﹤0.01%	3247

Charles Schwab's TGAN Position: Q2 2024 in Review

Charles Schwab sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 78,073 shares — an estimated $383K sold.

Charles Schwab first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $383K in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Charles Schwab reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Charles Schwab sold 78,073 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $383K.
Charles Schwab first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Charles Schwab's Transphorm, Inc. Common Stock position peaked at $383K in Q1 2024.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.